The importance of keeping weight gain associated with diabetes therapy low, especially in adolescents, is highlighted by the observation that young people with Type 1 diabetes often use insulin omission as a strategy to manage their weight 34,35, with a detrimental effect on glycaemic control, and complication risk. Here, INS is linked to type 1 diabetes mellitus.